Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geny Piro

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Current Opinion in Pharmacology|July 17, 2013
Rationale and clinical use of multitargeting anticancer agentsDavide Melisi, Geny Piro, Anna Tamburrino, et al.
Expert Review of Molecular Diagnostics|March 17, 2018
Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validationGeny Piro, Carmine Carbone, Raffaela Santoro, et al.
Frontiers in Pharmacology|May 4, 2013
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapyAnna Tamburrino, Geny Piro, Carmine Carbone, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 18, 2017
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapyRaffaela Santoro, Carmine Carbone, Geny Piro, et al.
Anticancer Research|March 31, 2018
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional ActivityRaffaela Santoro, Marco Zanotto, Carmine Carbone, et al.
Parasites & Vectors|October 16, 2020
Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasisNatalia Tiberti, Dora Buonfrate, Carmine Carbone, et al.
Cells|October 14, 2022
Immunogenic Cell Death: An Emerging Target in Gastrointestinal CancersMarta Chiaravalli, Alexia Spring, Antonio Agostini, et al.
Nutrients|April 23, 2022
Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary ApproachesChiara Cencioni, Ilaria Trestini, Geny Piro, et al.
Biomedicines|May 27, 2017
Toll-Like Receptor 9 Agonists for Cancer TherapyDavide Melisi, Melissa Frizziero, Anna Tamburrino, et al.
International Journal of Molecular Sciences|June 10, 2023
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of TherapyEnrico Gurreri, Giannicola Genovese, Luigi Perelli, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Current Opinion in Pharmacology|July 17, 2013
Rationale and clinical use of multitargeting anticancer agentsDavide Melisi, Geny Piro, Anna Tamburrino, et al.
Expert Review of Molecular Diagnostics|March 17, 2018
Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validationGeny Piro, Carmine Carbone, Raffaela Santoro, et al.
Frontiers in Pharmacology|May 4, 2013
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapyAnna Tamburrino, Geny Piro, Carmine Carbone, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 18, 2017
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapyRaffaela Santoro, Carmine Carbone, Geny Piro, et al.
Anticancer Research|March 31, 2018
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional ActivityRaffaela Santoro, Marco Zanotto, Carmine Carbone, et al.
Parasites & Vectors|October 16, 2020
Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasisNatalia Tiberti, Dora Buonfrate, Carmine Carbone, et al.
Cells|October 14, 2022
Immunogenic Cell Death: An Emerging Target in Gastrointestinal CancersMarta Chiaravalli, Alexia Spring, Antonio Agostini, et al.
Nutrients|April 23, 2022
Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary ApproachesChiara Cencioni, Ilaria Trestini, Geny Piro, et al.
Biomedicines|May 27, 2017
Toll-Like Receptor 9 Agonists for Cancer TherapyDavide Melisi, Melissa Frizziero, Anna Tamburrino, et al.
International Journal of Molecular Sciences|June 10, 2023
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of TherapyEnrico Gurreri, Giannicola Genovese, Luigi Perelli, et al.
Pageof 6